Logo image of TRIL

Trillium Therapeutic (TRIL) Stock News

NASDAQ:TRIL - Nasdaq -

18.44  +0.47 (+2.62%)

After market: 18.47 +0.03 (+0.16%)

TRIL Latest News, Press Relases and Analysis

News Image
a year ago - Benzinga

30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond

The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substances like psilocybin and MDMA to treat mental health conditions, this sector has attracted growing attention and investment. 

Mentions: TSLA ENVB CYBN

News Image
2 years ago - Benzinga

Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person

This year’s edition of the Benzinga Psychedelics Capital Conference, THE place to be for those interested or already involved in the space, will take place on April 13, following our established Cannabis Capital Confere

Mentions: BWVI ENVB

News Image
3 years ago - Oncolytics Biotech® Inc.

Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders and Appoints James T. Parsons to its Board of Directors

/PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), today announced the voting results from its Annual General Meeting (AGM) of Shareholders...

Mentions: ONCY DMAC

News Image
3 years ago - InvestorPlace

7 of the Best Stocks to Buy for Their Free Cash Flow

These stocks to buy have a stable business outlook and robust free cash flows. They can create value through dividends and repurchases.

Mentions: AAPL TGT GOOG NVDA ...

News Image
3 years ago - Trillium Therapeutics Inc.

Trillium Therapeutics Receives Final Court Order Approving Arrangement

CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage...

Mentions: TRIL.CA

News Image
3 years ago - Trillium Therapeutics Inc.

Trillium Securityholders Approve Acquisition by Pfizer

CAMBRIDGE, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage...

Mentions: TRIL.CA

News Image
3 years ago - The Motley Fool

Why Curis Stock Perked Up in August

The biotech's shares rode the wave of buyout speculation higher last month.

Mentions: CRIS PFE

News Image
3 years ago - The Motley Fool

Why Investors Should Love Pfizer's Acquisition of Trillium

This deal checks off several boxes for Pfizer.

Mentions: PFE

News Image
3 years ago - Barron's

Biotech Is Due for a Comeback. 5 Stocks That Could Lead a Revival.

Investors and analysts say there is plenty of value to find in the sector.

Mentions: BLUE ACAD ABCL SRPT ...

News Image
3 years ago - Investor's Business Daily

Stock Market Rally Hits Highs, Fed Chief Powell Backs Bond Taper; Palo Alto, CrowdStrike, Williams-Sonoma, Dick's Sporting Goods In Focus: Weekly Review

The stock market hit new highs while Fed chief Jerome Powell backed a bond taper.

Mentions: PANW CRWD CRM SNOW ...

News Image
4 years ago - Zacks Investment Research

Tap the Red Hot Biotech Sector With These 2 Leveraged ETFs

Investors could easily tap the bullish trend by considering a near-term long on the biotech sector.

Mentions: JNJ PFE MRNA

News Image
4 years ago - StockMarket.com

Top Health Care Stocks To Invest In Now? 5 For Your Late 2021 Watchlist

With health care giants like Pfizer firing on all cylinders, these health care stocks could be in the spotlight now.

Mentions: PFE BPTH OCGN CARA ...

News Image
4 years ago - InvestorPlace

4 Top Stock Trades for Tuesday: PFE, MRNA, NVDA, BABA

Pfizer, Moderna, Nvidia and Alibaba were our top stock trades for Tuesday. Now, let's get a look at the charts as the market hits new highs.

Mentions: PFE NVDA BABA